|

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

RECRUITINGSponsored by Vanderbilt-Ingram Cancer Center
Actively Recruiting
SponsorVanderbilt-Ingram Cancer Center
Started2010-06-03
Est. completion2027-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT01205815

Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion criteria

* Pathologically-proven diagnosis of melanoma.
* Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Exclusion criteria

* Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
* Any patient unable or unwilling to provide consent.

Conditions2

CancerMelanoma

Locations1 site

Vanderbitl-Ingram Cancer Center
Nashville, Tennessee
Vanderbilt-Ingram Service for Timely Access800-811-8480

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.